Accessibility Menu
Zivo Bioscience logo

Zivo Bioscience

(OTC) ZIVO

Current Price$4.60
Market Cap$17.89M
Since IPO (2003)-100%
5 Year-82%
1 Year-74%
1 Month+231%

Zivo Bioscience Financials at a Glance

Market Cap

$17.89M

Revenue (TTM)

$119.03K

Net Income (TTM)

-$9.89M

EPS (TTM)

-$2.60

P/E Ratio

-1.77

Dividend

$0.00

Beta (Volatility)

0.31 (Low)

Price

$4.60

Volume

94

Open

$4.60

Previous Close

$4.60

Daily Range

$4.60 - $4.60

52-Week Range

$1.11 - $19.65

ZIVO News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zivo Bioscience

Industry

Personal Products

Employees

7

CEO

John Bernard Payne, MBA

Headquarters

Bloomfield Hills, MI 48304, US

ZIVO Financials

Key Financial Metrics (TTM)

Gross Margin

33%

Operating Margin

-83%

Net Income Margin

-83%

Return on Equity

0%

Return on Capital

3%

Return on Assets

-15%

Earnings Yield

-56.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.89M

Shares Outstanding

3.89M

Volume

94

Avg. Volume

4.66K

Financials (TTM)

Gross Profit

$39.93K

Operating Income

-$9.85M

EBITDA

-$9.84M

Operating Cash Flow

-$3.29M

Capital Expenditure

$0.00

Free Cash Flow

-$3.29M

Cash & ST Invst.

$67.06K

Total Debt

$637.20K

Zivo Bioscience Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

$17.89M

N/A

Market Cap/Employee

$2.56M

N/A

Employees

7

N/A

Net Income

-$3.01M

-87.8%

EBITDA

-$2.99M

-87.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

-$570.14K

-144.3%

Accounts Receivable

$0.00

-100.0%

Inventory

$259.79K

N/A

Long Term Debt

$202.24K

+74.1%

Short Term Debt

$434.96K

+214.8%

Return on Assets

-14.91%

N/A

Return on Invested Capital

2.78%

N/A

Free Cash Flow

-$1.11M

-23.0%

Operating Cash Flow

-$1.11M

-23.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACHFFArch Biopartners Inc.
$0.32+0.92%
OTLCOncotelic Therapeutics, Inc.
$0.06+3.40%
RLFTFMindMaze Therapeutics Holding S.A.
$0.48+0.13%
PSYBFPsyBio Therapeutics Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CZRCaesars Entertainment
$29.10+0.01%
IUSBiShares Trust - iShares Core Universal Usd Bond ETF
$46.18+0.00%
RCATRed Cat
$14.34+0.34%
ATPCAgape Atp
$6.41+1.25%

Questions About ZIVO

What is the current price of Zivo Bioscience?

Zivo Bioscience is trading at $4.60 per share.

What is the 52-week range for Zivo Bioscience?

Over the past 52 weeks, Zivo Bioscience has traded between $1.11 and $19.65.

How much debt does Zivo Bioscience have?

As of the most recent reporting period, Zivo Bioscience reported total debt of $637.20K.

How much cash does Zivo Bioscience have on hand?

Zivo Bioscience reported $67.06K in cash and cash equivalents in its most recent financial results.

What is Zivo Bioscience’s dividend yield?

Zivo Bioscience does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.